Opening https://www.globenewswire.com/news-release/2023/02/16/2610286/0/en/Alterity-Therapeutics-Receives-Regulatory-Authorization-in-France-and-Austria-to-Proceed-with-ATH434-Phase-2-Clinical-Trial.html